Patients with DUSP22 -R ALCL tended to have a higher initial complete response rate than the patients with DUSP22-NR neoplasms, but this difference did not reach statistical significance ( P =0.08).
← all excerpts
<i>DUSP22</i> rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma.
1
0.0800
0.0800